Nyra Medical’s first-in-human CARLEN study evaluates a novel transcatheter mitral leaflet implant, exploring less invasive repair for functional mitral regurgitation while preserving native valve function.

IV fluid shortages are forcing maternity teams to conserve supplies, prioritize high-risk obstetric care, and adopt alternative hydration strategies while maintaining safe childbirth outcomes.

Atrial fibrillation can distort aortic stenosis severity measurements, making comprehensive echocardiographic assessment, standardized protocols, and multimodal evaluation essential for accurate diagnosis and treatment decisions.

New research reveals critical gaps in financial toxicity screening and navigation for adolescent and young adult cancer patients, highlighting opportunities to improve equitable, comprehensive oncology care.

New research reshapes autism care, revealing delayed diagnoses in females and highlighting media-driven off-label prescribing, reinforcing the need for evidence-based screening, diagnosis, and treatment.

An observational study links GLP-1 medications to lower breast cancer risk in overweight women, highlighting promising preventive potential while reinforcing continued screening and randomized research.

A large real-world study found GLP-1 medications commonly cause gastrointestinal side effects, highlighting the need for proactive counseling, individualized dosing, and structured symptom management.

A real-world study shows rimegepant effectively prevents migraines in treatment-resistant patients, including some after CGRP antibody failure, supporting earlier use for improved long-term outcomes.

The expiration of enhanced ACA subsidies is driving coverage losses, higher premiums, and underinsurance, increasing uncompensated care while straining patients, providers, and healthcare systems nationwide.

Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.